Polyvinyl Alcohol (PVA), represented by the chemical formula [C2H4O]n, stands out as a highly biocompatible, water-soluble synthetic polymer. Widely valued across the global pharmaceutical sector, PVA functions primarily as a pharmaceutical excipient, binder, and structural matrix former. Its properties are dictated by its degree of polymerization and hydrolysis. Depending on these two factors, pharmaceutical-grade PVA can be tailored to meet exact specifications—from fast-dissolving oral films to resilient, sustained-release hydrogels.
As regulatory requirements for drug delivery systems intensify, manufacturers require high-purity PVA that complies with the major global monographs (USP, Ph. Eur., JP, ChP). In oral solid dosages, ophthalmic formulations, and transdermal systems, PVA delivers reliable performance, consistent chemical stability, and exceptional safety. Partnering with a reliable supplier like Shandong Pulisi Chemical Co., Ltd. ensures that these critical excipient requirements are met with strict quality controls.
Viscosity and hydrolysis levels are easily adjusted during manufacturing to target specific solubility profiles, barrier performance, and mechanical strength requirements.
PVA features a highly favorable toxicological profile, making it a safe excipient for ophthalmic, oral, topical, and transdermal pharmaceutical preparations.
Its exceptional film-forming capabilities shield active pharmaceutical ingredients (APIs) from moisture, oxygen, and other degradation factors.
Depending on regional pharmacopoeias and specific formulation goals, pharmaceutical-grade Polyvinyl Alcohol is used across several targeted application scenarios:
In tablet formulations, PVA is widely used as a premium film-coating agent. It offers excellent tensile strength, low oxygen permeability, and outstanding adhesion to tablet surfaces. This prevents moisture ingress, helping to stabilize hygroscopic active pharmaceutical ingredients (APIs). In wet granulation processes, PVA serves as an efficient binder, ensuring tablets maintain mechanical integrity during transport while dissolving reliably upon ingestion.
Because of its low surface tension, high water retention, and excellent lubricating properties, PVA is a common ingredient in over-the-counter and prescription ophthalmic drops. It mimics natural tear mucins, adhering to the ocular surface to provide long-lasting hydration and relief from irritation. Crucially, high-purity ophthalmic-grade PVA is free of trace catalysts and heavy metals, minimizing ocular toxicity.
Modern therapeutic systems utilize PVA-based hydrogels as polymeric matrices for transdermal patches. Its chemical stability enables the incorporation of various hydrophilic and lipophilic APIs. By cross-linking the polymer chains through physical or chemical methods, manufacturers can precisely control the rate of drug release, providing consistent dosing over hours or days.
In advanced biomedical engineering, PVA hydrogels are prepared using freeze-thaw physical cross-linking. This creates porous, highly elastic structures that mimic soft human tissue. These structures are used in wound dressings to maintain a moist healing environment, as well as in implantable drug-delivery depots that slowly release therapies directly to target areas.
The pharmaceutical industry is shifting from traditional, mass-produced dosage forms toward personalized medicine and advanced delivery platforms. Polyvinyl Alcohol is well-positioned to play a key role in this transition due to its versatility and clean safety profile. Below is the technical roadmap highlighting the development of PVA from a standard excipient to a critical component of smart biomaterials.
PVA filament is increasingly used as a water-soluble matrix in Fused Deposition Modeling (FDM) 3D printing. This technology enables pharmacies and clinics to print custom, patient-specific pill geometries, allowing for precise, individualized release profiles.
Future research is focused on modifying PVA with smart co-polymers to create hydrogels that respond to changes in pH, temperature, or enzyme concentration. This allows targeted drug release in specific sections of the gastrointestinal tract.
Combining PVA with biodegradable polyesters like PLGA helps form nanoparticles that improve the solubility and bioavailability of poorly water-soluble APIs, paving the way for advanced systemic drug delivery.
The global demand for pharmaceutical excipients is growing, driven by a rise in chronic diseases and a steady increase in oral solid dosage production. Major pharmaceutical companies are actively seeking suppliers who can provide consistent, batch-to-batch quality to avoid costly formulation delays. In this highly regulated landscape, security of supply and compliance with international standards are critical priorities.
As Western manufacturers face rising energy costs and complex logistical bottlenecks, Chinese manufacturers have established themselves as key suppliers. This growth is driven by deep integration of raw material access, advanced chemical refining technologies, and robust logistics infrastructure.
Established in 2006 (Stock Code: 307785), Shandong Pulisi Chemical Co., Ltd. has built a reputation for excellence in the global chemical sector. The company leverages several key supply chain advantages to ensure timely, cost-effective deliveries:
Shandong Pulisi Chemical Co., Ltd. was established in 2006 (Stock Code: 307785). The company focuses on petrochemicals, mining chemicals, feed chemicals, and pharmaceutical chemicals. At present, the company has established long-term and stable partnerships with Fortune Global 500 companies such as China National Petroleum Corporation and Saint-Gobain. We always take customer demand as the core orientation and provide tailored solutions to help customers strengthen their market competitiveness.
The company has passed ISO9001:2015 Quality Management System Certification and German BV Certification, and has been awarded multiple honors such as Foreign-Oriented Economic Enterprise, Alibaba Demonstration Base, and Contribution Enterprise. In 2023, the company successfully went public with stock code: 307785.
The company upholds the corporate culture philosophy of "Customer First, Rapid Response; Striving as the Foundation, Efficient Collaboration; Integrity and Uprightness, Agile Adaptation." We focus on providing compliant and high-quality products and supporting services, and are committed to becoming a long-term and stable partner for customers.
(Strict Statement: Shandong Pulisi has not established branches outside of Shandong Province. If there is any act of impersonating Shandong Pulisi, our company will reserve the right to pursue legal responsibilities.)
Our operations are certified under international quality and safety frameworks. This structure ensures every batch shipped complies with international pharmaceutical regulatory standards.
Since our founding in 2006, Shandong Pulisi has actively participated in trade shows and chemical exhibitions around the world. These events help us connect with international partners, share our developments in high-purity chemical production, and better understand local regulatory requirements.
Chemicals for sizing, advanced printing, dyeing, and leather processing.
Safe agricultural chemicals, animal feed additives, and food-grade compounds.
Polymer modifiers and raw materials for cement, adhesives, and paints.
Flotation agents and processing chemicals for mineral extraction.
Viscosifiers and fluid-loss control additives for demanding drilling systems.
Industrial solvents and sanitizing agents for hygiene applications.
Coagulants and scale inhibitors for municipal and industrial water plants.
Base polymers, plasticizers, and stabilizers for compound manufacturing.
Exporting to more than 100 countries and regions with fully localized logistical support and customs clearance procedures.
Over 20 years of chemical manufacturing and international trading experience, serving a network of more than 1,000 corporate clients.
ISO 9001, German BV, Kosher, Halal, K-REACH, and FAMI-QS certified, ensuring compliance with international regulatory standards.
Integrated production chains enable us to offer competitive, transparent pricing based on customization requirements.
Strategic warehouses at major ports (Qingdao, Tianjin, Khorgos) allow for rapid dispatch and short transit times.
Our technical and customer service teams support clients through formulation development, testing, and batch approval.
Pulisi
